0001437749-23-004868.txt : 20230228
0001437749-23-004868.hdr.sgml : 20230228
20230228122321
ACCESSION NUMBER: 0001437749-23-004868
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221021
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nussbaum Ran
CENTRAL INDEX KEY: 0001609805
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 23681764
MAIL ADDRESS:
STREET 1: C/O KITE PHARMA, INC.
STREET 2: 2225 COLORADO AVENUE
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2022-10-21
2022-10-25
0001668243
UroGen Pharma Ltd.
URGN
0001609805
Nussbaum Ran
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Ordinary Shares
2022-10-21
4
M
0
47999
5.94
A
1485168
I
Managing
member of
entities
affiliated with
Pontifax
Management
III G.P.
(2011) Ltd
Stock Option (right to buy)
5.94
2022-10-21
4
M
0
32723
0
D
2018-12-27
2022-12-27
Ordinary Shares
32723
0
I
By Pontifax (Israel) III Limited Partnership
Stock Option (right to buy)
5.94
2022-10-21
4
M
0
15276
0
D
2018-12-27
2022-12-27
Ordinary Shares
15276
0
I
By Pontifax Cayman III Limited Partnership
On October 25, 2022, the reporting person filed a Form 4 that inadvertently reported 1,481,927 shares of securities beneficially owned following reported transaction instead of 1,485,168 shares.
/s/ Jason D. Smith, Attorney-in-Fact
2023-02-28